Reducing sample sizes in two-stage phase II cancer trials by using continuous tumour shrinkage end-points. (2011)

First Author: Wason JM
Attributed to:  Hub in Trials Methodology Research (MRC Biostatistics Unit, Cambridge) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ejca.2010.12.007

PubMed Identifier: 21239164

Publication URI: http://europepmc.org/abstract/MED/21239164

Type: Journal Article/Review

Volume: 47

Parent Publication: European journal of cancer (Oxford, England : 1990)

Issue: 7

ISSN: 0959-8049